Investment Summary |
|
|---|---|
| Date | 2012-10-02 |
| Target | Cloudant |
| Sector | Internet Software and Services |
| Investor(s) | Eight Roads |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1969 |
| PE ASSETS | 11.0B USD |
| Size | Mega |
| Type | Sector Focused |
Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 52 of 293 |
| Sector: Internet Software and Services M&A | 5 of 60 |
| Type: Venture M&A Deals | 40 of 266 |
| State: Massachusetts M&A | 8 of 33 |
| Country: United States M&A | 20 of 119 |
| Year: 2012 M&A | 14 of 17 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-08-23 |
AbsolutData Technologies
Alameda, California, United States AbsolutData Technologies, Inc. is an AI and Advanced Analytics company serving Global 500 clients. Absolutdata's award-winning NAVIK AI platform and 300 world-class data scientists significantly enhance the ability to engineer superior business outcomes for clients through the use of cutting-edge AI and Analytics. Absolutdata creates scalable business impact for enterprise clients across the globe. Using a combination of its proprietary NAVIK AI platform and AI & Advanced Analytics services, Absolutdata enables its clients to grow faster, increase profitable revenue, and develop deeper relationships with their customers. AbsolutData Technologies was formed in 2001 and is based in Alameda, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-10-04 |
LigoCyte Pharmaceuticals
Bozeman, Montana, United States LigoCyte Pharmaceuticals is a privately-held biopharmaceutical company specializing in innovative vaccine products. Its lead product, a vaccine to prevent norovirus gastroenteritis, is in phase I/II of clinical development. LigoCyte Pharmaceuticals was founded in 1998 and is based in Bozeman, Montana. |
Sell | $60M |